Request for Offers No. 4/2020 – IPF – research service (NASH)
The request for offers is carried out with the reference to the application process for the grant titled:
IPF: DEVELOPMENT OF A FIRST-IN-CLASS SMALL MOLECULE DRUG CANDIDATE FOR TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS THROUGH CHITOTRIOSIDASE INHIBITION (POIR.01.01.01-00-0551/15)
co-financed by the European Union Funds and because of the competitiveness principle. We hereby look for Contractor ready to perform the service:
In vivo study on therapeutic efficacy of two chitinase inhibitors and reference compound Elafibranor in mouse model of non-alcoholic steatohepatitis (NASH)